Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2019-08-28 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Director's Dealing 2019
Director's Dealing Classification · 100% confidence The document is titled 'Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer' (Notification of transactions in Coloplast shares and related securities by persons discharging managerial responsibilities and persons closely associated with them). It explicitly references 'Markedsmisbrugsforordningen art. 19' (Market Abuse Regulation Article 19), which mandates the disclosure of insider transactions by management personnel. The content details specific transactions (option exercise and sales) by the CFO, Anders Lonning-Skovgaard. This directly corresponds to the definition of Director's Dealing (DIRS).
2019-08-28 Norwegian
Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier
Director's Dealing Classification · 100% confidence The document is a notification of transactions made by a person discharging managerial responsibilities (Paul R. Marcun, a member of the executive board) at Coloplast A/S. It details the exercise of share options and the subsequent sale of shares, which is a classic 'Director's Dealing' or 'Insider Trading' disclosure required under the Market Abuse Regulation (MAR). Although the document contains a link to an attachment, the text itself provides the full disclosure of the transaction details, fitting the definition of a Director's Dealing report.
2019-08-27 Danish
Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 99% confidence The document explicitly details transactions (exercise of share options and subsequent sale of shares) conducted by an Executive Vice President (Paul R. Marcun) in the company's shares. This activity is reported under the obligation of the Market Abuse Regulation article 19, which mandates reporting on transactions by persons discharging managerial responsibilities (PDMRs). This perfectly matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The structure is a regulatory disclosure form, not a general announcement of a report (RPA) or a comprehensive annual/interim report.
2019-08-27 English
Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by a member of the executive board (Paul R. Marcun) of Coloplast A/S. It explicitly details the exercise of options and the subsequent sale of shares, citing the Market Abuse Regulation (Markedsmisbrugsforordningen). This falls directly under the definition of 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2019-08-27 English
Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions made by a person discharging managerial responsibilities (Paul R. Marcun, Executive Vice President) in Coloplast shares. It explicitly references the Market Abuse Regulation (MAR) article 19, which governs the reporting of insider dealings. This fits the definition of a Director's Dealing (DIRS) report.
2019-08-27 English
Director's Dealing 2019
Director's Dealing Classification · 100% confidence The document explicitly details 'Trading in Coloplast shares by board members, executives or associated persons' and references 'Market Abuse Regulation article 19'. It reports specific transactions (exercise of share options/purchase and sale of shares) by an Executive Vice President, Paul R. Marcun. This content directly corresponds to the reporting of personal share transactions by company directors and executives, which is classified as Director's Dealing (DIRS). The document is a direct report of insider trades, not an announcement of a report (RPA) or a general regulatory filing (RNS).
2019-08-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.